Professor Lisa Volpatti developed a targeted approach that directs anti-inflammatory proteins to diseased arteries, reducing ...

Over the past few years, access to health research has become easier than ever, yet understanding it seems to be getting harder. A study is published, a striking number is pulled out of context, ...

Millions of people take statins like Simvastatin (above) to lower their cholesterol levels. Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart ...

The company, founded by UC Berkeley scientists including Jennifer Doudna, is preparing to test its lead candidate STX-1150 in ...

For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Border 2 box office collection day 1: Sunny Deol, Varun Dhawan, Diljit Dosanjh's star power beats Dhurandhar opening 8 ...

Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...

Chances are, your cholesterol isn’t something you think too much about. When it comes to your health, your thoughts may already be preoccupied with figuring out more ways to get protein, how to get ...

Panelists discuss how global LDL thresholds below 55 mg/dL influence care and challenge U.S. practice to evolve. Panelists discuss how international guidelines—particularly European ones—have adopted ...

Once upon a time, cholesterol was simple. This molecule, it was proclaimed, came in two varieties: an artery-clogging “bad” sort and an artery-clearing “good” one. The difference was not in the ...

Every 40 seconds, someone in the U.S. has a heart attack or stroke, and in most cases, it’s their first. 1 The good news? The risk for these devastating events can actually be significantly reduced by ...